Skip to main content

Table 3 Post-booster anti-HBs titre by vaccine group.

From: A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines

Anti-HBs titer (mIU/ml) Group 1 (N = 25) Hexavac® n (%) Group 2 (N = 5) Infanrix Hexa® n (%) p-value
< 10 2 (8.0) 0 1.0000*
10–99 4 (16.0) 2 (40.0) 0.2854**
≥ 100 19 (76.0) 3 (60.0) -
  1. * < 10 vs ≥ 10; ** 10–99 vs ≥ 100